Abstract:Abstract Glioblastoma, a malignant brain cancer, is highly invasive and resistant to multimodal treatment partly due to distorted vasculature and exacerbated inflammation in its tumor microenvironment. The glycoprotein pentraxin-3 (PTX3), a modulator of inflammation, is correlated with the severity of some cancers. However, the mechanism responsible for the oncogenic role of PTX3 in GBM malignancy remains unclear. Our previous study examined the role of PTX3 in GBM growth, angiogenesis, and invasion using in vitro glioblastoma cells and in vivo/pre-clinical GBM models, proteomic profiling, molecular and biochemical approaches. Over-expression of PTX3 in U87 brain tumor cells correlated with cell cycle progression, increased migratory potential, and survival under hypoxic conditions. PTX3 over-expression increased blood vessel forming ability of endothelial cells. Importantly, PTX3 over-expression increased tumor growth, micro-vessel density, and invasion in brains of an orthotopic mouse model. To understand the molecular mechanisms associated with PTX3 mediated tumor aggressiveness, we further examined the effects of PTX3 on mRNA levels of genes involved in motility/invasion, angiogenesis, and inflammation using pathway specific gene arrays. PTX3 over expression was associated with the 5-fold upregulation of hypoxia-inducible factor (HIF)-1α, which in turn transactivates several genes essential for tumor growth and survival. Indeed, higher PTX3 expression led to increased mRNA levels of genes involved in motility, angiogenesis, and inflammation. The upregulated motility associated genes included ARHGEF7, RAC1, and PAK, a protein kinase involved in intracellular signaling pathways downstream of integrins. Inflammatory genes that were increased in expression included IL-1beta, CCL3, CCL5, and CXCL5 that amplifies a proinflammatory cytokine response via a phosphatidylinositol 3-kinase-NF-kappa B pathway. The upregulated pro-angiogenic genes included interleukin-8 (IL-8), matrix metalloproteinase-2 (MMP2), and vascular endothelial growth factor (VEGF), expression of which correlates with GBM malignancy. Interestingly PTX3 decreased the levels of thrombospondin-1 that inhibits angiogenesis. Thus, PTX3 appears to trigger multiple signaling pathways that enhance the aggressive behavior of tumor cells. Taken together, our study indicates that targeted therapy such as blocking PTX3 may reduce the aggressiveness of glioblastomas through regulation of multiple molecular pathways. Citation Format: Umadevi V. Wesley, Ian Sutton, Dylan E. Nelson, Paul A. Clark, Robert J. Dempsey. Pentraxin-3 associated up-regulation of genes involved in motility, angiogenesis, and inflammation in glioblastoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 2510.

Prostaglandin F2 receptor inhibitor (PTGFRN) a cell adhesion molecule, promotes cell growth and migration in glioblastoma

Identification of the Role of TRPM8 in Glioblastoma and Its Effect on Proliferation, Apoptosis and Invasion of the U251 Human Glioblastoma Cell Line

A Novel Classifier Combining G Protein-Coupled Receptors and the Tumor Microenvironment is Associated with Survival Status in Glioblastoma.

Prostaglandin F2 Receptor Negative Regulator (PTGFRN) Expression Correlates With a Metastatic‐like Phenotype in Epidermoid Carcinoma, Pediatric Medulloblastoma, and Mesothelioma

Multi-Omics Analysis of Glioblastoma and Glioblastoma Cell Line: Molecular Insights Into the Functional Role of GPR56 and TG2 in Mesenchymal Transition

Tmic-82. Characterization Of Genetic Markers And Biological Processes Underlying The Transition Of Glioblastoma Cells From A Differentiated To A Stem-Cell-Like State

NCAPG Promotes Tumor Progression and Modulates Immune Cell Infiltration in Glioma

Quantitative proteomic analysis of GnRH agonist treated GBM cell line LN229 revealed regulatory proteins inhibiting cancer cell proliferation

Comprehensive Analysis Reveals Epithelial Growth Factor Receptor as a Potential Diagnostic Biomarker in Glioblastoma Multiforme

Cyclic nucleotide phosphodiesterase-1C (PDE1C) drives cell proliferation, migration and invasion in glioblastoma multiforme cells in vitro

SYST-26 INVESTIGATING THE FUNCTIONAL ROLE OF GPNMB IN GLIOBLASTOMA AND THE TUMOR IMMUNE MICROENVIRONMENT AND ITS TARGETED ELIMINATION USING CAR-T CELLS

Intracellular Progesterone Receptor and cSrc Protein Working Together to Regulate the Activity of Proteins Involved in Migration and Invasion of Human Glioblastoma Cells

Prostate-Specific Membrane Antigen (PSMA) Promotes Angiogenesis of Glioblastoma Through Interacting With ITGB4 and Regulating NF-κB Signaling Pathway

CRMP2 Phosphorylation Drives Glioblastoma Cell Proliferation

Prostate-Specific Membrane Antigen (PSMA) Promotes Angiogenesis of Glioblastoma Through Interacting With ITGB4 and Regulating NF-B Signaling Pathway

Exploring ncRNA-mediated regulation of EGFR signalling in glioblastoma: From mechanisms to therapeutics

Complementary roles of EP2 and EP4 receptors in malignant glioma

Abstract 4300: Cell cycle pathway gene regulation in glioblastoma multiforme (GBM) and GBM derived stem cells: Implicating Pentraxin 3 upregulation

Role of Podoplanin (PDPN) in Advancing the Progression and Metastasis of Glioblastoma Multiforme (GBM)

P12.03.A MULTIMODAL ANALYSIS OF GLIOBLASTOMA REVEALS THE POTENTIAL OF CXCR7-CXCL12 IN GBM CELLS SENSITIZES GBM TO IMMUNE CHECKPOINT BLOCKADE THERAPY

Abstract 2510: Pentraxin-3 associated up-regulation of genes involved in motility, angiogenesis, and inflammation in glioblastoma